Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00235196 · ClinicalTrials.gov registry record · Phase 4
Evaluation of the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers
A Phase 4 study, sponsored by Ethicon.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT00235196 is a Phase 4 study that has completed, run by Ethicon. The registered enrollment target is 48 participants.
The verdict
NCT00235196, a Phase 4 study, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
This is a randomized (1:1), prospective, open label, multicenter, comparative study to be examine the effectiveness of Collagen-ORC Antimicrobial matrix, a new wound dressing, on diabetic foot ulcers.
Interventions
- DEVICE Collagen ORC Antimicrobial Matrix (CAM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2004-07 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00235196
The ClinicalTrials.gov registry entry for NCT00235196 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Collagen ORC Antimicrobial Matrix (CAM) is the first listed.
NCT00235196 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00235196 about?
NCT00235196 is a clinical study titled "Evaluation of the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers". This is a randomized (1:1), prospective, open label, multicenter, comparative study to be examine the effectiveness of Collagen-ORC Antimicrobial matrix, a new wound dressing, on diabetic foot ulcers.
What is the current status of trial NCT00235196?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2004-07. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00235196?
The interventions under investigation include: Collagen ORC Antimicrobial Matrix (CAM) (DEVICE).
Who is sponsoring clinical trial NCT00235196?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.